Scansteen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.5% 6.6% 9.9% 30.7% 27.6%  
Credit score (0-100)  41 35 24 1 2  
Credit rating  BBB BBB BB C B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  456 305 134 9.2 -37.0  
EBITDA  304 171 7.3 -101 -38.1  
EBIT  242 163 0.2 -101 -38.1  
Pre-tax profit (PTP)  236.6 156.3 -5.7 -99.2 -35.9  
Net earnings  183.0 121.6 -5.7 -99.2 -35.9  
Pre-tax profit without non-rec. items  237 156 -5.7 -99.2 -35.9  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,133 1,141 1,021 304 146  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,439 1,230 1,046 328 166  

Net Debt  -1,232 -1,030 -1,005 -316 -163  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  456 305 134 9.2 -37.0  
Gross profit growth  -22.1% -33.0% -56.1% -93.1% 0.0%  
Employees  2 1 1 1 0  
Employee growth %  0.0% -50.0% 0.0% 0.0% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,439 1,230 1,046 328 166  
Balance sheet change%  16.2% -14.6% -14.9% -68.6% -49.4%  
Added value  304.1 170.6 7.3 -93.5 -38.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -247 -14 -14 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 -2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  53.2% 53.5% 0.1% -1,091.7% 103.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.9% 12.2% 0.0% -14.4% -14.5%  
ROI %  21.8% 14.4% 0.0% -15.0% -15.9%  
ROE %  16.7% 10.7% -0.5% -15.0% -15.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  78.7% 92.8% 97.6% 92.6% 88.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -405.0% -603.9% -13,759.4% 313.4% 428.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  4.7 13.8 41.5 13.5 8.3  
Current Ratio  4.7 13.8 41.5 13.5 8.3  
Cash and cash equivalent  1,231.8 1,030.1 1,004.7 315.5 163.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,118.4 1,134.2 1,003.5 304.2 146.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  152 171 7 -94 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  152 171 7 -101 0  
EBIT / employee  121 163 0 -101 0  
Net earnings / employee  91 122 -6 -99 0